BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 26874845)

  • 21. Inhibitory effects of sanguinarine on human liver cytochrome P450 enzymes.
    Qi XY; Liang SC; Ge GB; Liu Y; Dong PP; Zhang JW; Wang AX; Hou J; Zhu LL; Yang L; Tu CX
    Food Chem Toxicol; 2013 Jun; 56():392-7. PubMed ID: 23500771
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Ding B; Ji X; Sun X; Zhang T; Mu S
    Xenobiotica; 2020 Aug; 50(8):913-918. PubMed ID: 32026737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory mechanisms of celastrol on human liver cytochrome P450 1A2, 2C19, 2D6, 2E1 and 3A4.
    Jin C; He X; Zhang F; He L; Chen J; Wang L; An L; Fan Y
    Xenobiotica; 2015; 45(7):571-7. PubMed ID: 25811791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anemarsaponin BII inhibits the activity of CYP3A4, 2D6, and 2E1 with human liver microsomes.
    Wang M; Jiang W; Zhou J; Xue X; Yin C
    Pharm Biol; 2020 Dec; 58(1):1064-1069. PubMed ID: 33103940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AM-2201 Inhibits Multiple Cytochrome P450 and Uridine 5'-Diphospho-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes.
    Kim JH; Kwon SS; Kong TY; Cheong JC; Kim HS; In MK; Lee HS
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28287454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of human cytochrome P450 isoforms involved in the 3-hydroxylation of quinine by human live microsomes and nine recombinant human cytochromes P450.
    Zhao XJ; Yokoyama H; Chiba K; Wanwimolruk S; Ishizaki T
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1327-34. PubMed ID: 8968357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of tubeimoside I on the activity of cytochrome P450 enzymes in human liver microsomes.
    Wang R; Zheng K; Liu Y; Ji S; Tang Y; Wang J; Jiang R
    Xenobiotica; 2024 Feb; 54(2):57-63. PubMed ID: 38166553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the in vitro and in vivo metabolic pathway and cytochrome P450 inhibition/induction profile of Huperzine A.
    Lin PP; Li XN; Yuan F; Chen WL; Yang MJ; Xu HR
    Biochem Biophys Res Commun; 2016 Nov; 480(2):248-253. PubMed ID: 27751854
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Ji X; Ding B; Wu X; Liu F; Yang F
    Xenobiotica; 2021 Mar; 51(3):262-267. PubMed ID: 33115303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereoselective interaction between tetrahydropalmatine enantiomers and CYP enzymes in human liver microsomes.
    Sun SY; Wang YQ; Li LP; Wang L; Zeng S; Zhou H; Jiang HD
    Chirality; 2013 Jan; 25(1):43-7. PubMed ID: 23001793
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Zhao H; Xue S; Meng Q; Zhou C
    Xenobiotica; 2021 Sep; 51(9):977-982. PubMed ID: 34176447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Naltrexone Hydrochloride on Cytochrome P450 1A2, 2C9, 2D6, and 3A4 Activity in Human Liver Microsomes.
    AlRabiah H; Ahad A; Mostafa GAE; Al-Jenoobi FI
    Eur J Drug Metab Pharmacokinet; 2018 Dec; 43(6):707-713. PubMed ID: 29744741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of triptolide hydroxylation by cytochrome P450 in human and rat liver microsomes.
    Li W; Liu Y; He YQ; Zhang JW; Gao Y; Ge GB; Liu HX; Huo H; Liu HT; Wang LM; Sun J; Wang Q; Yang L
    Xenobiotica; 2008 Dec; 38(12):1551-65. PubMed ID: 18982531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of lycopene on cytochrome P450 isoenzymes and P-glycoprotein by using human liver microsomes and Caco-2 cell monolayer model.
    Kong L; Song C; Ye L; Xu J; Guo D; Shi Q
    Int J Food Sci Nutr; 2018 Nov; 69(7):835-841. PubMed ID: 29322841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of cytochrome P450 by ethambutol in human liver microsomes.
    Lee SY; Jang H; Lee JY; Kwon KI; Oh SJ; Kim SK
    Toxicol Lett; 2014 Aug; 229(1):33-40. PubMed ID: 24910189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro evaluation of the inhibition potential of echinacoside on human cytochrome P450 isozymes.
    Wu Y; Qiao A; Lin S; Chen L
    BMC Complement Med Ther; 2022 Feb; 22(1):46. PubMed ID: 35180866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro inhibition of human liver cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT) enzymes by rose bengal: system-dependent effects on inhibitory potential.
    Kazmi F; Haupt LJ; Horkman JR; Smith BD; Buckley DB; Wachter EA; Singer JM
    Xenobiotica; 2014 Jul; 44(7):606-14. PubMed ID: 24405273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Agrimoniin inhibits the activity of CYP1A2, 2D6, and 3A4 in human liver microsomes.
    Zhou Y; Xian Q; Wei H; Zhou J; Li S; Yang J; Zhou X; Li Y
    Xenobiotica; 2021 Dec; 51(12):1360-1365. PubMed ID: 34806927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enantioselective inhibition of Cytochrome P450-mediated drug metabolism by a novel antithrombotic agent, S002-333: Major effect on CYP2B6.
    Bhateria M; Ramakrishna R; Puttrevu SK; Saxena AK; Bhatta RS
    Chem Biol Interact; 2016 Aug; 256():257-65. PubMed ID: 27387538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In Vitro Inhibition of Human CYP450s 1A2, 2C9, 3A4/5, 2D6 and 2E1 by Grandisin.
    Habenschus MD; Moreira FL; Lopes NP; de Oliveira ARM
    Planta Med; 2017 May; 83(8):727-736. PubMed ID: 28073119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.